| http://www.w3.org/ns/prov#value | - In an alternative targeted therapeutic regimen, an anti-CD27L is coupled or conjugated directly to a drug moiety, such as, for example, a toxin (e.g., an auristatin, or other toxin mentioned supra), which upon internalisation of the antibody-toxin complex following binding to CD27L results in targeted cell death of CD27L positive cells.
|
